Key result
A previously healthy 27-year-old woman developed acute fulminant myocarditis following influenza vaccination and was successfully rescued using veno-arterial extracorporeal membrane oxygenation.
Why the study?
Inactivated influenza vaccination is generally safe with mild side effects, but rare, severe adverse events can occur.
Case Report (n=1)
No
Influenza vaccination can rarely be associated with acute fulminant myocarditis, which may require mechanical circulatory support such as ECMO for successful management.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare post-vaccination fulminant myocarditis needing ECMO; leaves open incidence, causality, and surveillance needs.
The inactivated influenza vaccination is generally safe with mostly mild side effects. We report a rare but fatal adverse event following influenza vaccination. A previously healthy 27-year-old woman who received the influenza vaccination 3 days before presenting to the emergency department had rapidly aggravating dyspnea and mental deterioration. She was diagnosed as having acute fulminant myocarditis with refractory cardiogenic shock, which was successfully managed with veno-arterial extracorporeal membrane oxygenation. The cardiac function of the patient recovered in 3 weeks.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) conducted a case report in Acute fulminant myocarditis (n=1). Quadrivalent inactivated influenza vaccination was evaluated. A previously healthy 27-year-old woman developed acute fulminant myocarditis following influenza vaccination and was successfully rescued using veno-arterial extracorporeal membrane oxygenation.
Synapse has enriched 10 related papers. Consider them for comparative context: